Veramed has acquired Boston-based Data Management, Biostatistics and Medical Writing services company CTDS in a deal which will enhance our global presence and broaden our data management capability.Specialized biometrics and data management providers are proving to be an effective solution to the biotech industry’s need for flexibility, speed and agility. These providers offer specialized expertise in data collection and analysis, ensure accurate results; maintain data quality and regulatory compliance; enhance resource efficiency; expedite decision-making; and provide tailored solutions to sponsor companies. Collaborating with companies like Veramed mitigates risks, provides access to advanced tools, and boosts credibility with biotech investors, contributing to more effective research, quicker decision-making, and improved prospects for funding and success.
About CTDS
Founded in 2005 by Terri Sampo, Clinical Trial Data Services supports small to midsize sponsor companies helping them to take the next step towards market approval for their drug or device product. CTDS’s meticulous oversight, personalized service and understanding and dedication to process is a perfect fit for Veramed’s existing reputation for quality and delivery.
About Veramed
Veramed is a high-performing partner for statistical consultancy, data management, clinical trial reporting and automation, DMC services, and evidence and value generation. We’re a pioneering CRO redefining intelligent healthcare decision-making and paving the way for pharma and biotech clients by offering tailored biometrics solutions that scale and adapt as needs grow.
